Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    paediatrics

    Kawasaki disease

    Also known as: Kawasaki syndrome, Mucocutaneous lymph node syndrome, KD

    Kawasaki disease is an acute systemic vasculitis predominantly affecting paediatric populations, characterized by vessel inflammation with the potential for severe coronary artery sequelae. Suspected presentations necessitate immediate paediatric referral and inpatient management. Standard medical protocols—including intravenous immunoglobulin (IVIG), acetylsalicylic acid, and serial echocardiography—remain the primary interventions and must not be delayed or substituted for TCM modalities. Supportive TCM care should only be considered following stabilisation and in consultation with the treating medical team. The provided evidence, encompassing urinary biomarker studies, IVIG case reports, and computational analysis of Salvia miltiorrhiza (Danshen), does not demonstrate clinical efficacy for acupuncture or the specified herbal formulae; the included asthma paper is unrelated. The traditional patterns detailed herein serve as conceptual frameworks for the convalescent phase only; they are not validated therapeutic protocols for acute Kawasaki disease nor predictors of coronary pathology.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere strictly to the prescribed pharmacological regimen and attend all scheduled echocardiography and specialist consultations.
    • •Maintain a comprehensive clinical log including core temperature, fluid intake, urinary output, activity levels, and any emerging symptoms for medical review.
    • •Ensure adequate rest periods and restrict physical exertion according to the specific parameters defined by the attending cardiologist.
    • •Coordinate vaccination schedules with the clinical team post-immunoglobulin administration; maintain acetylsalicylic acid dosages as prescribed and refrain from independent alteration of the immunisation plan.

    Cautions & Contraindications

    See sources
    • •Do not use needling or herbs to postpone assessment, immunoglobulin, prescribed aspirin or cardiac follow-up. The supplied case report describes cardiovascular complications and monitored hospital treatment, not evidence for substitution with TCM.[]
    • •Known IgA deficiency or previous immunoglobulin reactions require specialist-controlled treatment planning. One uneventful case using an IgA-depleted preparation does not establish safety for all children with IgA deficiency.[]
    • •Do not prescribe Danshen on the assumption that molecular docking establishes clinical efficacy, paediatric safety or compatibility with antithrombotic treatment. The supplied study is computational and cannot establish these outcomes.[]

    When to reassess or seek care again

    See sources

    Hospital and cardiology review schedules take priority. If medically cleared supportive care is considered, document baseline sleep, appetite, fluid intake, urine output and activity tolerance; review within seven days and stop if there is no meaningful benefit. Fever recurrence, reduced intake or urine, worsening fatigue, new bruising or suspected adverse effects require same-day medical advice; cardiorespiratory symptoms require emergency escalation. Symptom improvement does not establish coronary recovery.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Frontiers in allergy · 2026
    2. Pediatric research · 2026
    3. BMC pediatrics · 2026
    4. Medicine · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.